Zhejiang Tianyu Pharmaceutical Co Ltd (300702) — Capital Reinvestment Ratio
Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥233.18 Million) in capital expenditures (CN¥70.00 Million). See 300702 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Tianyu Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Zhejiang Tianyu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 300702 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see Zhejiang Tianyu Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | CN¥344.64 Million | CN¥168.95 Million | ▼ -39.7% |
| 2020 | 0.81x | CN¥622.18 Million | CN¥506.05 Million | ▼ -1.7% |
| 2019 | 0.83x | CN¥427.84 Million | CN¥354.10 Million | ▼ -63.8% |
| 2018 | 2.29x | CN¥78.57 Million | CN¥179.89 Million | ▲ +80.1% |
| 2017 | 1.27x | CN¥88.52 Million | CN¥112.54 Million | ▲ +95.0% |
| 2016 | 0.65x | CN¥164.74 Million | CN¥107.44 Million | ▼ -84.6% |
| 2015 | 4.24x | CN¥14.75 Million | CN¥62.59 Million | ▲ +326.7% |
| 2014 | 0.99x | CN¥80.44 Million | CN¥79.99 Million | ▼ -42.2% |
| 2013 | 1.72x | CN¥39.73 Million | CN¥68.31 Million | — |